News Daily News Worse TAVI and M-TEER Outcomes Seen With Low-Volume Operators Michael O'Riordan January 22, 2026
News Conference News TCT 2025 Sirolimus-Coated Balloon Meets Mark in De Novo Lesions and ISR: SELUTION Michael O'Riordan October 26, 2025
News Opinion Editor's Corner ACC 2025 What’s Going to Be Hot at ACC 2025? Michael O'Riordan March 26, 2025
News Features Initial US Commercial TriClip Cases Offer Hope, but Reimbursement Still a Big Question L.A. McKeown August 09, 2024
News Daily News Apixaban May Have Advantages in Patients With Liver Cirrhosis and AF Michael O'Riordan July 09, 2024
News Daily News Lower Mortality With M-TEER vs Surgery, but Devil Is in the Details Michael O'Riordan January 25, 2024
News Daily News Similar Outcomes With Enteric-Coated and Uncoated Aspirin: ADAPTABLE Todd Neale October 06, 2023
News Conference News ESC 2022 INVICTUS: More Deaths, Stroke With Rivaroxaban in Rheumatic Heart Disease AF Michael O'Riordan August 28, 2022
News Conference News ACC 2022 What’s Going to Be Hot at ACC 2022, In Person or Virtual Shelley Wood March 28, 2022
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for November 2020 Shelley Wood November 30, 2020
News Daily News ‘Aspirin-Free’ Antiplatelet Strategy Feasible After PCI, Pilot Study Suggests Michael O'Riordan September 18, 2020
News Daily News Rivaroxaban May Yet Protect After a Hospital Stay: MARINER Caitlin E. Cox June 25, 2020
News Conference News SCAI 2019 Cancer and CV Disease Care: What’s Known? What Lies Ahead for Cardio-Oncology? Yael L. Maxwell May 30, 2019
News Conference News CRT 2018 Wait Continues for a Win With Biodegradable-Polymer DES in Patients at High Bleeding Risk: BIO-RESORT Michael O'Riordan March 08, 2018
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for November 2016 Shelley Wood November 30, 2016